Allarity Therapeutics, Inc. (ALLR) Year-over-year earnings per share growth for the last twelve months

Graphic logo of allarity.com (ALLR)

Allarity Therapeutics is creating a closed-loop precision medicine ecosystem by combining targeted therapy with AI-driven diagnostics. The quarter-over-quarter EPS trend reflects a financial dependence on investments, as commercial products are still undergoing testing and -103.90 determines the current status of the parameter. The company is implementing innovations that predict tumor response to drugs, eliminating ineffective treatments and saving lives.

ALLR: Allarity Therapeutics, Inc. Quarterly EPS earnings growth 07/04/2022 - 11/18/2026

Allarity Therapeutics, Inc. (ALLR) - metric breakdowns and financial figures

- share price and expert price forecast:
Comprehensive company analysis:Allarity Therapeutics
Finished products of allarity.com

Liquidity shortages and scaling challenges regarding DRP diagnostics at Allarity Therapeutics (ALLR) jeopardize business sustainability until strategic financing is secured. The current value of -103.90 reflects the dynamics of net earnings per share, where a rolling calculation of quarterly growth captures the deviation of actual development rates from targets, allowing for an assessment of the asset's liquidity risks through the quarterly EPS growth rate.